Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Knowing when to reassess your financial plan is key to success. Stay informed about the right times to make adjustments.
23,689 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Two insurance giants reveal how revenue trends shape investor returns. This guide breaks down who earns more, where p...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...
Verisign sits at the backbone of the web. It runs the registry for .COM and .NET and powers how users reach sites eve...
A notable fund exit from Sprinklr during a year of rapid AI adoption offers real-world lessons for investors. Here’s ...
As AI reshapes markets, critics say consumer data funds the surge while a handful of platforms claim the profits. Thi...
CoStar Group blends a high performing CRE data backbone with a slower moving homes marketplace. This piece breaks dow...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
The second half of 2026 could reward investors who pick AI stock winners with durable competitive advantages. This gu...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
Two automotive giants draw the attention of investors with shifting revenue engines. This deep dive breaks down Ford ...
More than 30 confirmed screwworm cases have been reported in Texas and New Mexico, including two dogs. Vets issue urg...